Dynavax
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Dynavax and other ETFs, options, and stocks.About DVAX
Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the provision of discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older.
CEORyan Spencer
CEORyan Spencer
Employees405
Employees405
HeadquartersEmeryville, California
HeadquartersEmeryville, California
Founded1996
Founded1996
Employees405
Employees405
DVAX Key Statistics
Market cap1.23B
Market cap1.23B
Price-Earnings ratio-22.12
Price-Earnings ratio-22.12
Dividend yield—
Dividend yield—
Average volume1.79M
Average volume1.79M
High today$10.97
High today$10.97
Low today$10.48
Low today$10.48
Open price$10.94
Open price$10.94
Volume3.62M
Volume3.62M
52 Week high$14.63
52 Week high$14.63
52 Week low$9.22
52 Week low$9.22
DVAX News
Benzinga 3d
Dynavax Says Investigational Shingles Vaccine At Par With GSK's Vaccine In Early-Stage StudyDynavax Technologies Corporation DVAX announced topline results from Part 1 of its randomized, observer-blinded, and active-controlled Phase 1/2 clinical trial...
Seeking Alpha 3d
Dynavax says shingles shot performed on par with GSK’s Shingrix in Phase 1/2 trialHealthcare On the Move Dynavax says shingles shot performed on par with GSK’s Shingrix in Phase 1/2 trial Aug. 21, 2025 9:06 AM ET Dynavax Technologies Corpora...
TipRanks 3d
Dynavax Announces Positive Results for Shingles VaccineElevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...
People also own
Based on the portfolios of people who own DVAX. This list is generated using Robinhood data, and it’s not a recommendation.